Award notice, first published as presolicitation
Anti CD20 Antibodies
36E79724R0006
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes tomorrowNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 4 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 10 daysNov 12
Description
As published on SAM.gov with the solicitation of February 5, 2024.
Extend Closing Date Effective 2/5/2024 This amendment is being issued to extend the closing date for solicitation 36E79724R0006 for Anti-CD20 Antibodies. The solicitation due date has been extended to February 20, 2024 and all offers are due by 2:30PM Central Time.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- TG Therapeutics Inc.
- UEI
- JKPZKD19WMD7
- CAGE
- 8TBE4
- Vendor location
- Edison, NJ
- Contract
- 36E79724D0024
- Obligated
- $0.00, potential $186,776,520
- Actions
- 8 between April 17, 2024 and September 2, 2026
- Competition
- Full and Open Competition, 4 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for Ublituximab-Xiiy 150mg/6ml Injection (Anti-Cd20 Antibodies with TG Therapeutics. Period of Performance June 17, 2024 - June 16, 2025 with Four ONE-YEAR Options.
- Match
- award number 36E79724D0024 equals the contract number; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
January 19, 2024
Presolicitation
Anti CD20 Antibodies (VA-24-00025874)
Due February 26, 2024 at 3:30 PM EST. SAM.gov, notice 57a3cc4023814b9683b0e7039900b59d
January 25, 2024
Solicitation, originally presolicitation
Anti CD20 Antibodies (VA-24-00025874)
Due February 8, 2024 at 3:30 PM EST. SAM.gov, notice 76e43e096c6d4225892d217699c4a091
January 26, 2024
Solicitation
Anti CD20 Antibodies (VA-24-00025874)
Due February 19, 2024 at 3:30 PM EST. SAM.gov, notice 110a98ef99394970ac51e79c26f5afc7
January 29, 2024
Solicitation
Anti CD20 Antibodies (VA-24-00025874)
Due February 19, 2024 at 3:30 PM EST. SAM.gov, notice 7a2edcb9d3ee46f8bffe1b4b0b15f2c1
February 5, 2024
Solicitation
Anti CD20 Antibodies (VA-24-00025874)
Due February 20, 2024 at 3:30 PM EST. SAM.gov, notice 43d5425c05c443da843675da8af7a720
April 17, 2024
Award notice
Awarded to TG Therapeutics Inc. Edison 08837 Jib for $186,776,520. SAM.gov, notice 5efea17b278941f7ae9ba627116a29be
Points of contact
- Youlanda Duggar, Contract SpecialistYoulanda.Duggar@va.gov708-786-4943